Sign Up to like & get
recommendations!
2
Published in 2023 at "Acta oncologica"
DOI: 10.1080/0284186x.2023.2209266
Abstract: Abstract Purpose Patients with synchronous metastatic head and neck squamous cell carcinomas (mHNSCC) are at risk of locoregional progression associated with significant morbidity and mortality. The aim of this study is to assess whether the…
read more here.
Keywords:
locoregional treatment;
synchronous metastatic;
systemic therapy;
metastatic head ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "BJU international"
DOI: 10.1111/bju.15603
Abstract: OBJECTIVES To compare clinical outcomes with anti-PD(L)1 immune checkpoint inhibitors (ICIs) in patients with advanced urothelial carcinoma (aUC) who have vs have not undergone radical surgery (RS) or radiation (RT) prior to developing metastatic disease.…
read more here.
Keywords:
line;
treatment;
association;
prior locoregional ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Revista do Colegio Brasileiro de Cirurgioes"
DOI: 10.1590/0100-69912017004010
Abstract: OBJECTIVE to compare the outcome of liver transplantation for hepatocarcinoma in submitted or not to locoregional treatment and downstaging regarding survival and risk of recurrence in transplant waiting list patients. METHODS retrospective study of patients…
read more here.
Keywords:
waiting list;
treatment;
liver;
patients waiting ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1083297
Abstract: Approximately 6% of metastatic breast cancers arise de novo. While systemic therapy (ST) remains the treatment backbone as for patients with metachronous metastases, locoregional treatment (LRT) of the primary tumor remains a controversial method. The…
read more here.
Keywords:
oncology;
oncology locoregional;
locoregional treatment;
breast ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Vaccines"
DOI: 10.3390/vaccines8020191
Abstract: Background: Previous locoregional treatment could affect the response to nivolumab in platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The aim of this study is to evaluate the impact of the clinicopathological characteristics…
read more here.
Keywords:
response;
treatment;
platinum refractory;
locoregional treatment ... See more keywords